摘要:

Modern IV therapy is less than a century old. Yet, it was known that medications could be injected into a vein as early as the 1600s. Because of a lack of scientific methods, original attempts to deliver IV fluids and drugs met with little success. Two world wars brought in the era of modern IV therapy. However, the greatest advance in drugs, equipment, and procedures has occurred in the past 25 years.

ISSN:0896-5846    

出版商:OVID    

年代:1996

数据来源: OVID

摘要:

Vinorelbine tartrate (Navelbine, Burroughs Wellcome Company, Research Park, NC) is a semisynthetic analog of vinblastine that has been approved by the Food and Drug Administration for use in the treatment of advanced, unresectable non-small cell lung cancer. It has a favorable safety profile and can safely and easily be administered in the outpatient setting on a weekly basis. The major toxicity is severe, granulocytopenia (absolute neutrophil count < 500 cells/mm3), that occurs in approximately 40% of treated patients. This granulocytopenia is rapidly reversible, and does not increase in severity with subsequent cycles. Despite the high incidence of granulocytopenia, only about 8% of patients require hospitalization for the treatment of febrile neutropenia. This article also reviews information concerning the incidence and management of the other major side effects including constipation, paresthesias, decreased deep tendon reflexes, myalgia, and injection site reactions. Guidelines for the safe administration of this agent along with suggestions for patient education are also presented. The potential significance of the impact that this new agent may have in the treatment of advanced, unresectable non-small cell lung cancer and advanced breast cancer is stressed.

ISSN:0896-5846    

出版商:OVID    

年代:1996

数据来源: OVID

摘要:

Administration of intravenous antibiotics in cystic fibrosis has been facilitated by the use of midline catheters; percutaneous lines inserted through a peripheral vein and advanced into a large but noncentral vein. In a randomized study, a 23-gauge silastic catheter (Vygon EC, Cirencester, United Kingdom) was compared with the Hydrocath (Viggo-Spectromed, Swindon, United Kingdom), a 22-gauge hydrophillic coated polyurethane catheter inserted using the Seldinger technique. Fifty eight courses of intravenous antibiotics were given, 28 through the Hydrocath (median age 11 years, range 1.5—17.5 years) and 30 through the silastic catheter, (median age 11 years, range 0.5–17.5). Mean line survival was equal. The Hydrocath took longer to insert and was associated with more pain on insertion. However, administration of antibiotics was easier through the Hydrocath and overall satisfaction was higher in those who had the Hydrocath. Both catheters performed well, but administration of antibiotics was easier through the Hydrocath.

ISSN:0896-5846    

出版商:OVID    

年代:1996

数据来源: OVID

摘要:

Application of the topical anesthetic cream to the antecubital fossa 60 minutes before insertion of the peripherally inserted central catheters resulted in significant vasocon-striction and/or vasospasm in 24 patients. Catheter insertion was difficult in all 24 patients. Advancement of the peripherally inserted central catheter was impossible in six patients. Of the 51 patients that did not have the topical anesthetic pre-catheter insertion, there were no difficulties in placing the lines, nor were there any vasocon-striction and/or vasospasm. This group included 66 adults and 9 children.

ISSN:0896-5846    

出版商:OVID    

年代:1996

数据来源: OVID

摘要:

The intent of this article is to provide intravenous nurses with options for marketing and promoting their IV teams in institutions to enhance viability of the team concept and promote quality nursing care for the consumer. The article supplies options for a business plan to present to administration to promote the team concept both in the hospital and in alternate site settings.

ISSN:0896-5846    

出版商:OVID    

年代:1996

数据来源: OVID

摘要:

With the multiple external forces dictating rule and regulatory, third party payer/ reimbursement, and accreditation changes for the home infusion industry, identifying methods for managing the changes while maintaining quality in patient and organization outcomes has become essential. The challenge for the home infusion manager, nurse, pharmacist, and other healthcare professionals is to effectively anticipate, measure, monitor, and manage changes for the operations and clinical aspects of service.

ISSN:0896-5846    

出版商:OVID    

年代:1996

数据来源: OVID

ISSN:0896-5846    

出版商:OVID    

年代:1996

数据来源: OVID